IVO Health develops interpretable risk models for insurers to prevent mental health crises and optimise healthcare utilisation.

Kapacity’s software shifts energy consumption in buildings to periods of lower electricity prices and higher renewable energy production, achieving lower electricity costs for customers and reducing carbon emissions.

InvenireX is developing real-time, ultra-sensitive DNA detection tools powered by the latest object-detection neural networks – to accelerate life science research.

Interpolate Labs has built an AI control tower that detects model drift in computer vision systems to prevent costly prediction errors across healthcare, defence and agriculture.

Infinitopes trains immunology to prevent metastases and is designing and developing novel and affordable cancer vaccines.

Hydra Manufacturing has developed a hybrid additive manufacturing process to help manufacturers of technical ceramics to develop next-gen products, reducing time-to-market and improving part quality.

Hychor is developing novel electrolyser technology to produce hydrogen from seawater without desalination, improving sustainability and efficiency by avoiding the need for freshwater and intensive seawater refinement.

HyCarb has developed next-generation methane splitting technology to enable local production of high-value graphitic carbon and affordable hydrogen.

Humanloop’s AI tools work alongside employees, allowing them to automate mundane tasks. This technology makes it easy to rapidly annotate data, train and deploy natural language processing (NLP) models – with humans in the loop.

Holistic AI has built the leading governance platform to deliver continuous oversight across the full AI lifecycle, enabling confident innovation at scale.

Hexis is a health and human performance app that supports individuals to positively restructure their habits and behaviours. Hexis’ human coaches and carbohydrate coding engine motivate users to achieve their personal health and performance goals.

Sensore has developed a new flexible fabric pressure sensor that leverages graphene technology and AI to help healthcare providers and wheelchair users prevent pressure ulcers.

GambitBio is creating a novel at-home saliva-based lateral flow test for early cancer detection of the most common cancers.

Eyesight Electronics leverages cutting-edge digital vision therapy software to eliminate preventable blindness, with a focus on Amblyopia.

Ethomix has developed a new generation of movement biomarkers for higher precision prediction of complications and drug efficacy – to accelerate drug trials and reduce hospital stays.

Eterna Biologics is developing a CRISPR-based RNA steric blocker capable of blocking RNA more effectively and with fewer off-target effects compared to current leading RNA therapeutics.

Metamorph Materials is developing net-negative carbonaceous materials that reduce the environmental impact of Li-ion battery production while maintaining high performance standards.

Doubleword (formerly TitanML) is the new standard for high performance inference in enterprise AI, leveraging years of research across quantum physics and low-memory machine learning.

Concinnity Genetics is accelerating the design of gene therapies using AI, creating systems that are more predictable, controllable and safe.

CamVolt develops intelligent control systems that enhance battery lifetime, performance and safety by maintaining optimal internal pressure in lithium-ion and next-generation cells.

Machine learning-driven health insurance providing specialist cover for type 2 diabetes and heart disease.

Bactery has developed affordable technology that harvests electrons produced by bacteria in soil.

AURApeutics uses ultrasound-activated nanoparticles to shatter the defences of drug-resistant chronic infections, making existing antibiotics effective again.

Astroscreen uses the latest machine learning techniques and human intelligence to detect astroturfing campaigns – protecting brands and safeguarding democracy.